Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.50 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 8/20 | 0.49 |
| ▸ | TMPRSS2 | O15393 | 2/20 | 0.49 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.48 |
| ▸ | F2 | P00734 | 2/20 | 0.48 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.48 |
| ▸ | F10 | P00742 | 2/20 | 0.48 |
| ▸ | PLAU | P00749 | 1/20 | 0.48 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.48 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.48 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.48 |
| ▸ | PTP4A3 | O75365 | 1/20 | 0.48 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.48 |
| ▸ | PLG | P00747 | 1/20 | 0.48 |
| ▸ | S100B | P04271 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.48 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.48 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20008757 | 0.91 | F12 (0.51) | ITGB3ITGA2BPRSS1TMPRSS2PRMT1 | |
| SCHEMBL20008745 | 0.89 | ITGB3 (0.47) | ITGB3ITGA2BPRSS1TMPRSS2PRMT1 | |
| SCHEMBL20008758 | 0.83 | ATM (0.42) | ITGB3ITGA2BPRSS1ACR | |
| SCHEMBL20008755 | 0.81 | TMPRSS2 (0.66) | PRSS1TMPRSS2PRMT1F2ST14 | |
| SCHEMBL20008711 | 0.81 | PRSS1 (0.67) | PRSS1TMPRSS2PRMT1F2ST14 | |
| SCHEMBL20008717 | 0.81 | ITGB3 (0.51) | ITGB3ITGA2BPRSS1TMPRSS15 | |
| SCHEMBL20008744 | 0.81 | FTO (0.46) | ITGB3ITGA2BPRSS1TMPRSS2F2 | |
| SCHEMBL20008762 | 0.79 | KMT2A (0.43) | ITGB3ITGA2BPRSS1ACR | |
| SCHEMBL20008628 | 0.78 | ITGB3 (0.53) | ITGB3ITGA2BPRSS1TMPRSS2PRMT1 | |
| SCHEMBL16808259 | 0.77 | ITGB3 (0.65) | ITGB3ITGA2BPRSS1TMPRSS2PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10335406-B2 | Opioid compositions resistant to overdose and abuse | ELYSIUM THERAPEUTICS, INC. (US) | 2019-07-02 | — | — | US | disclosed |
| US-20180085366-A1 | OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE | ELYSIUM THERAPEUTICS, INC. | 2018-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180085366-A1 | OPIOID COMPOSITIONS RESISTANT TO OVERDOSE AND ABUSE | OPRM1, OPRK1, OPRD1 | ITGB3 2592/4885ITGA2B 2485/4885PRSS1 952/4885 |
| US-10335406-B2 | Opioid compositions resistant to overdose and abuse | OPRM1, OPRK1, OPRD1 | ITGB3 2592/4885ITGA2B 2485/4885PRSS1 952/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.